Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02534779 · ClinicalTrials.gov registry record · NA
Assessing the Disintegration, Safety, and Acceptability of Placebo Vaginal Inserts for the Delivery of Vaginal Products
A NA study, sponsored by CONRAD.
- Completed
- Registry status
- NA
- Development phase
- 49
- Enrollment target
NCT02534779 is a NA study that has completed, run by CONRAD. The registered enrollment target is 49 participants.
The verdict
NCT02534779, a NA study, has completed, sponsored by CONRAD.
- COMPLETED
- Registry status
- NA
- Development phase
- 49 participants
- Enrollment target
Study Summary
This open-label study will examine the disintegration/disappearance time, safety, and acceptability of placebo vaginal inserts. Participants will use a placebo vaginal insert twice: first for an in-clinic disintegration/safety assessment, and a second time for an at-home acceptability assessment, with safety assessed at the following clinic visit.
Interventions
- OTHER Placebo Vaginal Insert
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 49 participants |
| Start Date | 2015-08 |
| Est. Completion | 2016-03 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02534779
The ClinicalTrials.gov registry entry for NCT02534779 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 49 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is CONRAD, which has 33 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Placebo Vaginal Insert is the first listed.
NCT02534779 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02534779 about?
NCT02534779 is a clinical study titled "Assessing the Disintegration, Safety, and Acceptability of Placebo Vaginal Inserts for the Delivery of Vaginal Products". This open-label study will examine the disintegration/disappearance time, safety, and acceptability of placebo vaginal inserts. Participants will use a placebo vaginal insert twice: first for an in-clinic disintegration/safety assessment, and a second time for an at-home acceptability assessment, wi...
What is the current status of trial NCT02534779?
This trial is currently completed. It is a NA study. The enrollment target is 49 participants. The study started on 2015-08. Estimated completion is 2016-03.
What interventions are being tested in trial NCT02534779?
The interventions under investigation include: Placebo Vaginal Insert (OTHER).
Who is sponsoring clinical trial NCT02534779?
This trial is sponsored by CONRAD, which has 33 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.